Company Filing History:
1 out of 832,912 Years Active: 2003
Title: Arie Rogel: Innovator in Recombinant Vaccines
Introduction
Arie Rogel is a notable inventor based in Western Galilee, IL. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant vaccines. His innovative work focuses on providing protection against viral diseases through advanced methods of vaccination.
Latest Patents
Rogel holds a patent for recombinant vaccines against Infectious Bursal Disease Virus (IBDV). This patent describes a stable vaccine that offers protection against the disease by utilizing viral proteins that are transgenically expressed in plant cells. The patent also outlines a method of vaccination that involves administering plant cells containing these viral proteins to animals in need of vaccination. Additionally, it includes a method for cloning viral protein and coding sequences into an expression system for effective vaccination.
Career Highlights
Throughout his career, Arie Rogel has focused on innovative approaches to vaccine development. His work has contributed to advancements in the field of veterinary medicine, particularly in enhancing the efficacy of vaccines against viral diseases. His dedication to research and development has positioned him as a key figure in biotechnology.
Collaborations
Rogel has collaborated with notable colleagues in his field, including Yehuda Stram and Ilan Sela. These collaborations have fostered a productive environment for innovation and have led to significant advancements in vaccine technology.
Conclusion
Arie Rogel's contributions to recombinant vaccine development highlight his commitment to improving animal health through innovative solutions. His work continues to influence the field of biotechnology and vaccine research.